Jorge Ivan Castillo-Quan, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Longevity | 6 | 2020 | 1069 | 1.240 |
Why?
|
| Lithium | 2 | 2019 | 601 | 0.990 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2019 | 430 | 0.660 |
Why?
|
| Pyrimidinones | 1 | 2019 | 370 | 0.590 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2017 | 364 | 0.570 |
Why?
|
| Aging | 5 | 2020 | 8626 | 0.500 |
Why?
|
| Sirolimus | 2 | 2019 | 1562 | 0.500 |
Why?
|
| Pyridones | 1 | 2019 | 712 | 0.500 |
Why?
|
| Hydrocortisone | 4 | 2010 | 1825 | 0.440 |
Why?
|
| Drosophila | 2 | 2019 | 1484 | 0.430 |
Why?
|
| Nutrigenomics | 2 | 2009 | 23 | 0.430 |
Why?
|
| Drosophila melanogaster | 4 | 2020 | 1704 | 0.410 |
Why?
|
| Trans-Activators | 2 | 2012 | 2924 | 0.400 |
Why?
|
| Caenorhabditis elegans | 2 | 2017 | 1416 | 0.390 |
Why?
|
| Metformin | 1 | 2016 | 829 | 0.350 |
Why?
|
| Adipose Tissue, White | 1 | 2012 | 345 | 0.340 |
Why?
|
| Insulin | 6 | 2017 | 6575 | 0.340 |
Why?
|
| Geriatrics | 1 | 2013 | 396 | 0.330 |
Why?
|
| Drosophila Proteins | 5 | 2020 | 1699 | 0.330 |
Why?
|
| Fibronectins | 1 | 2012 | 723 | 0.320 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 284 | 0.300 |
Why?
|
| Depressive Disorder | 2 | 2010 | 3748 | 0.280 |
Why?
|
| Cushing Syndrome | 1 | 2008 | 249 | 0.280 |
Why?
|
| Adipose Tissue, Brown | 1 | 2012 | 754 | 0.280 |
Why?
|
| Nerve Growth Factors | 1 | 2009 | 576 | 0.270 |
Why?
|
| Thiazolidinediones | 1 | 2009 | 476 | 0.260 |
Why?
|
| Hyperinsulinism | 1 | 2007 | 415 | 0.240 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2008 | 369 | 0.230 |
Why?
|
| Diabetes Complications | 1 | 2010 | 1359 | 0.220 |
Why?
|
| Diabetes Mellitus | 2 | 2012 | 5724 | 0.220 |
Why?
|
| Autophagy | 3 | 2020 | 1301 | 0.210 |
Why?
|
| Neuroprotective Agents | 1 | 2009 | 941 | 0.210 |
Why?
|
| Alzheimer Disease | 3 | 2017 | 7988 | 0.190 |
Why?
|
| Repressor Proteins | 1 | 2011 | 3020 | 0.180 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4328 | 0.160 |
Why?
|
| Parkinson Disease | 1 | 2011 | 2774 | 0.150 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2016 | 22 | 0.140 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 1617 | 0.140 |
Why?
|
| Gaucher Disease | 1 | 2016 | 112 | 0.140 |
Why?
|
| Xenobiotics | 1 | 2016 | 73 | 0.140 |
Why?
|
| Glucosylceramidase | 1 | 2016 | 124 | 0.140 |
Why?
|
| Group X Phospholipases A2 | 1 | 2015 | 1 | 0.130 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2015 | 14 | 0.130 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 438 | 0.130 |
Why?
|
| Mitochondria | 2 | 2020 | 3520 | 0.130 |
Why?
|
| Animals | 13 | 2020 | 168561 | 0.120 |
Why?
|
| United Nations | 1 | 2015 | 165 | 0.120 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 270 | 0.120 |
Why?
|
| Drug Combinations | 1 | 2019 | 1961 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2008 | 3861 | 0.120 |
Why?
|
| Caloric Restriction | 1 | 2016 | 302 | 0.110 |
Why?
|
| Lysosomes | 1 | 2016 | 893 | 0.100 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 904 | 0.100 |
Why?
|
| Neuroglia | 1 | 2016 | 925 | 0.100 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2017 | 849 | 0.100 |
Why?
|
| Biogenic Monoamines | 1 | 2010 | 50 | 0.090 |
Why?
|
| Models, Biological | 3 | 2017 | 9581 | 0.090 |
Why?
|
| Obesity | 1 | 2012 | 12705 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2017 | 2014 | 0.090 |
Why?
|
| Dietetics | 1 | 2008 | 35 | 0.080 |
Why?
|
| Models, Animal | 1 | 2015 | 2170 | 0.080 |
Why?
|
| Physical Conditioning, Animal | 1 | 2012 | 362 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2016 | 1402 | 0.080 |
Why?
|
| Depression | 1 | 2007 | 7733 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1887 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2020 | 23387 | 0.080 |
Why?
|
| Antioxidants | 1 | 2015 | 1659 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 2107 | 0.070 |
Why?
|
| Pituitary-Adrenal System | 1 | 2010 | 553 | 0.070 |
Why?
|
| Mexico | 1 | 2009 | 688 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2007 | 11695 | 0.070 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2010 | 604 | 0.070 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2010 | 703 | 0.070 |
Why?
|
| Receptor, Insulin | 2 | 2020 | 846 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2015 | 3081 | 0.060 |
Why?
|
| Diabetic Neuropathies | 1 | 2007 | 410 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2016 | 10248 | 0.060 |
Why?
|
| Humans | 14 | 2019 | 742088 | 0.050 |
Why?
|
| Gene Knockout Techniques | 2 | 2016 | 808 | 0.050 |
Why?
|
| Metabolic Diseases | 1 | 2008 | 657 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 820 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 7721 | 0.050 |
Why?
|
| Animals, Genetically Modified | 2 | 2017 | 1546 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 18006 | 0.050 |
Why?
|
| Genes, Mitochondrial | 1 | 2020 | 61 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9410 | 0.050 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 983 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2020 | 563 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 4751 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 2838 | 0.040 |
Why?
|
| Oleanolic Acid | 1 | 2017 | 43 | 0.040 |
Why?
|
| Thiadiazoles | 1 | 2017 | 55 | 0.040 |
Why?
|
| Lithium Chloride | 1 | 2017 | 87 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 297 | 0.030 |
Why?
|
| Quality of Life | 1 | 2015 | 12730 | 0.030 |
Why?
|
| Female | 4 | 2019 | 379592 | 0.030 |
Why?
|
| Rats | 1 | 2009 | 24265 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2012 | 12164 | 0.030 |
Why?
|
| Triazoles | 1 | 2017 | 907 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 1969 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2008 | 12695 | 0.020 |
Why?
|
| Mice | 2 | 2017 | 81045 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2017 | 5180 | 0.020 |
Why?
|
| Axons | 1 | 2016 | 1681 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 2203 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2699 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 21596 | 0.020 |
Why?
|
| Gene Expression | 1 | 2020 | 7790 | 0.020 |
Why?
|
| Hypertension | 1 | 2007 | 8455 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 162944 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 17400 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 1060 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 213127 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2015 | 4143 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 9387 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2017 | 5095 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2017 | 3574 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 12071 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 26343 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 19223 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 72145 | 0.010 |
Why?
|
| Cell Line | 1 | 2015 | 15994 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16665 | 0.010 |
Why?
|
| Male | 1 | 2016 | 349538 | 0.010 |
Why?
|
| Neurons | 1 | 2017 | 9325 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2008 | 9144 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 29717 | 0.010 |
Why?
|
| Pregnancy | 1 | 2008 | 29087 | 0.000 |
Why?
|